KRISTINA EKBERG

Kristina Ekberg stands as a distinguished Partner at HealthCap, a premier European venture capital firm renowned for its strategic investments in the life sciences sector. Her leadership is instrumental in HealthCap's mission to foster groundbreaking innovation in healthcare, particularly within biotechnology, pharmaceuticals, and medical technology.

Dr. Ekberg brings a formidable scientific foundation to her investment acumen. She holds a Ph.D. in Molecular Biology from Uppsala University, a testament to her deep understanding of biological processes at their most fundamental level. Following her doctoral studies, she further honed her research capabilities through postdoctoral work at the prestigious Karolinska Institute, contributing to cutting-edge scientific discovery.

Before transitioning into venture capital, Kristina Ekberg accumulated valuable industry experience. She served as a Senior Scientist at Biovitrum (now Sobi), a biopharmaceutical company, where she gained firsthand insight into drug development and research translation. Her career then progressed to Orexo AB, where she held the position of Director of Business Development, equipping her with critical skills in strategic partnerships, commercialization, and corporate growth within the pharmaceutical landscape.

Joining HealthCap in 2007, Kristina Ekberg quickly became a pivotal member of the investment team. As a Partner, she is deeply involved in all stages of the investment lifecycle, from rigorous due diligence and deal sourcing to active portfolio management. Her investment focus areas are squarely within drug development, advanced biotechnology, and innovative medical technology solutions that address significant unmet medical needs.

Dr. Ekberg's strategic insights and scientific expertise are invaluable to HealthCap's portfolio companies. She has served on the boards of numerous successful ventures, including PledPharma, Wilson Therapeutics, Cantargia, Targovax, and Forendo Pharma, among others. In these roles, she provides critical guidance on scientific strategy, clinical development, business expansion, and fundraising, helping these companies navigate the complex journey from scientific concept to market-ready products. Her work exemplifies HealthCap's commitment to building robust, high-impact life science companies that deliver significant value to patients and investors alike. Kristina Ekberg's dedication to advancing medical innovation underscores her reputation as a leading figure in European life sciences venture capital.